Global /Israel /Healthcare /Drug Manufacturers - Specialty & Generic /RAPH

Raphael Pharmaceutical Inc.

RAPH

• OTCMKTS: RAPH • Delayed

1.40USD 0%

As of 6 June 2026, Raphael Pharmaceutical Inc. has a market cap of $1.05M USD, ranking #48431 globally and #641 in Israel. It ranks #4304 in the Healthcare sector, and #350 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

48431

Country Rank

641

Sector Rank

4304

Industry Rank

350

Key Stats

Market Cap

$1.05MUSD

Enterprise Value

$1.04MUSD

Net Income (TTM)

-$1.28MUSD

PB Ratio

-0.7

Company Profile

Country (HQ)

Israel

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Shlomo Pilo open_in_new

Website

raphaelpharmaceutical.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	3K%	0%	0%	250%	0%	40%	-35%	-36%

News

Markets

Exchange	Ticker	Price	Quotes
OTC Markets (OTCMKTS / OTC) MIC: OTCM PRIMARY	RAPH Raphael Pharmaceutical Inc ISIN: US27785B2088 Shares Out.: Shares Outstanding: 20.176M¹ Shares Float: 8.603M² TV: TradingView: OTC: RAPH SA: Stock Analysis: OTC: RAPH YF: Yahoo Finance: RAPH GF: Google Finance: OTCMKTS: RAPH BA: Barron's: RAPH MS: Morningstar: PINX: RAPH	1.40 USD	TV: TradingView: OTC: RAPH SA: Stock Analysis: OTC: RAPH YF: Yahoo Finance: RAPH GF: Google Finance: OTCMKTS: RAPH BA: Barron's: RAPH MS: Morningstar: PINX: RAPH

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases. The company is headquartered in Tel Aviv-Jaffa, Israel.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Israel)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 4M%	24.2	Israel
Seach Medical Group Ltd. TLV: SEMG	$29.32M 84.78M ILS 3K%	57.3	Israel
Together Pharma Ltd. TLV: TGTR	$16.47M 47.62M ILS 1K%	22.9	Israel
IM Cannabis Corp. CSE: IMCC	$11.28M 15.74M CAD 975%	-	Israel
Allmed Solutions Ltd. TLV: ALMD	$11.27M 32.61M ILS 975%	-	Israel
Nextage Therapeutics Ltd. TLV: NXTG	$9.08M 26.25M ILS 765%	-	Israel

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 3M%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 2M%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 1M%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 1M%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 867K%	80.6	China
ABIVAX Société Anonyme EPA: ABVX	$8.79B 7.57B EUR 838K%	-	France

chevron_leftBack